Prevexxion RN


Marek's disease vaccine (live recombinant)

This medicine is authorised for use in the European Union.


Prevexxion RN is a veterinary vaccine used in one-day-old chicks to prevent death and disease and to reduce lesions caused by Marek’s disease (MD) virus (including very virulent MD virus).

MD is a herpesvirus infection of chickens which can cause paralysis of the wings and legs and tumours in various organs. Chickens become infected at an early age via inhalation of dander (flakes of skin) containing the virus which can remain infectious for several months after being shed from the body. Birds infected with MD virus can be carriers and shedders of the virus for life.

Prevexxion RN contains cells with a live recombinant strain of MD virus, serotype 1 called RN1250 that has been modified to increase its effectiveness and safety.

This EPAR was last updated on 10/01/2022

Authorisation details

Product details
Prevexxion RN
Agency product number
Active substance
Live recombinant Marek’s disease (MD) virus, serotype 1, strain RN1250
International non-proprietary name (INN) or common name
Marek's disease vaccine (live recombinant)
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address

55216 Ingelheim am Rhein

Product information

20/12/2021 Prevexxion RN - EMEA/V/C/005058 - IG/1450

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals for aves

Therapeutic indication

For active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by Marek’s disease (MD) virus (including very virulent MD virus).

Assessment history

How useful was this page?

Add your rating